Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Ventures & Investments Gms

Director at Outlook Therapeutics, Inc. (OTLK)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-24.9%
vs. S&P 500-26.3%
Beat the market0%
Paper profit on buys+$77K
Total bought / sold$5.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jun 1SEC OTLKOutlook Therapeutics, Inc. Buy 8,539,70922,092,068 held (+63%) $0.59 $5.0M +1.5%
  • Buy

    Director Ventures & Investments Gms bought $5.0M of OTLK at $0.59 — first open-market purchase in our records; raises the stake by 63%.